+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
[PCN193] Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France
Home
Publications
[PCN193] Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France
Back Home
[PCN193] Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France
2016 Value in Health
Godard, C. | Chouaid, C. | Angevin, E. | Loirat, D. | Ravonimbola, H. | Clay, E. | Millier, A. |
Volume: 19, Issue: 7, Pages: A743,
https://www.doi.org/10.1016/j.jval.2016.09.2266